What is the appropriate dose of Bromfed (brompheniramine, pseudoephedrine, guaifenesin) for a 30‑pound child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bromfed Dosing for a 30-Pound Child

For a 30-pound (approximately 13.6 kg) child aged 2 to under 6 years, administer 2.5 mL (½ teaspoonful) of Bromfed every 4 hours, not exceeding 6 doses in 24 hours 1.

Weight-Based Dosing Guidance

A 30-pound child typically falls into the 2 to under 6 years age category. The FDA-approved dosing for Bromfed (brompheniramine 2mg, pseudoephedrine 10mg, guaifenesin 30mg per 5mL) is:

  • 2 to under 6 years: 2.5 mL every 4 hours 1
  • 6 to under 12 years: 5 mL every 4 hours 1
  • Maximum: 6 doses per 24-hour period 1

Critical Safety Considerations

Age-Related Risks with Decongestants

Oral decongestants carry significant risks in young children. Use in infants and children under 6 years has been associated with serious adverse events including agitated psychosis, ataxia, hallucinations, and death 2. Even at recommended doses, pseudoephedrine may cause:

  • Tachyarrhythmias
  • Insomnia and hyperactivity
  • Loss of appetite and irritability
  • Palpitations 2

Important Contraindications and Precautions

Avoid or use with extreme caution if the child has:

  • Concurrent stimulant medications (e.g., ADHD medications) - may increase adverse events 2
  • Cardiovascular disease
  • Hyperthyroidism
  • Closed-angle glaucoma
  • Bladder neck obstruction 2

Monitoring Requirements

  • Blood pressure monitoring may be warranted, though elevation is rare in normotensive children 2
  • Watch for CNS stimulation (hyperactivity, insomnia) or paradoxical depression
  • Avoid concurrent caffeine or other stimulants 2

Pharmacologic Rationale

The brompheniramine component (first-generation antihistamine) provides H1-receptor blockade with anticholinergic drying effects. In children, a single 4 mg dose produces prompt onset (0.5 hours) with sustained peripheral H1-blockade lasting up to 30 hours, with a terminal elimination half-life of 12.4 hours 3. Pseudoephedrine acts as a nasal decongestant through α-sympathetic receptor-mediated vasoconstriction, with onset within 30 minutes and peak effect at 1 hour 1. The elimination half-life in children (3.1 hours) is significantly shorter than in adults 4.

Common Pitfalls to Avoid

  • Do not exceed the recommended dose - toxic doses of pseudoephedrine can cause CNS stimulation, tachycardia, hypertension, and cardiac arrhythmias 1
  • Do not combine with other cold medications - risk of ingredient duplication and overdose
  • Carefully assess risk-benefit in children under 6 years given documented safety concerns with oral decongestants in this age group 2
  • Be aware of serotonin syndrome risk if the child is on SSRIs or other serotonergic medications, as both dextromethorphan and brompheniramine have serotonergic potential 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.